• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Cancer in older adults: understanding cause and effects of chemotherapy-related toxicities.老年癌症患者：了解化疗相关毒性的原因及影响
Future Oncol. 2019 Aug;15(22):2557-2560. doi: 10.2217/fon-2019-0159. Epub 2019 Jul 24.
2
Toxicity of Cancer Therapies in Older Patients.老年患者的癌症治疗毒性。
Curr Oncol Rep. 2018 Jun 13;20(8):64. doi: 10.1007/s11912-018-0705-y.
3
Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.预测老年人化疗毒性：比较 CARG 毒性评分与肿瘤学家基于临床判断估计毒性的预测价值。
J Geriatr Oncol. 2019 Mar;10(2):202-209. doi: 10.1016/j.jgo.2018.08.010. Epub 2018 Sep 14.
4
Can we avoid the toxicity of chemotherapy in elderly cancer patients?我们能否避免老年癌症患者化疗的毒性？
Crit Rev Oncol Hematol. 2018 Nov;131:16-23. doi: 10.1016/j.critrevonc.2018.08.008. Epub 2018 Aug 28.
5
Determining chemotherapy tolerance in older patients with cancer.评估老年癌症患者的化疗耐受性。
J Natl Compr Canc Netw. 2013 Dec 1;11(12):1494-502. doi: 10.6004/jnccn.2013.0176.
6
Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study.泰国老年癌症患者化疗相关毒性和不良事件的风险因素：一项前瞻性研究。
Oncology. 2018;94(3):149-160. doi: 10.1159/000485078. Epub 2017 Dec 7.
7
Bevacizumab-associated diverticulitis: results of disproportionality analysis.贝伐单抗相关性憩室炎：不成比例分析结果
Expert Rev Clin Pharmacol. 2015 May;8(3):271-2. doi: 10.1586/17512433.2015.1041850.
8
Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients.HIV 感染者恶性肿瘤治疗中的药物相互作用。
Oncol Res Treat. 2017;40(3):120-127. doi: 10.1159/000458443. Epub 2017 Feb 24.
9
Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.癌症治疗引起的皮肤不良反应管理：专家小组建议
An Bras Dermatol. 2020 Mar-Apr;95(2):221-237. doi: 10.1016/j.abd.2020.01.001. Epub 2020 Feb 15.
10
Nanoparticle systems reduce systemic toxicity in cancer treatment.纳米粒子系统可降低癌症治疗中的全身毒性。
Nanomedicine (Lond). 2016 Jan;11(2):103-6. doi: 10.2217/nnm.15.166. Epub 2015 Dec 11.

引用本文的文献

1
Exploring factors affecting the adoption and use of digital health technologies among older adults with cancer: A qualitative study.探索影响老年癌症患者采用和使用数字健康技术的因素：一项定性研究。
Support Care Cancer. 2025 Aug 6;33(9):758. doi: 10.1007/s00520-025-09813-y.
2
Recent advances in non-invasive tracking of cell-based cancer immunotherapies.基于细胞的癌症免疫疗法非侵入性追踪的最新进展。
Biomater Sci. 2025 Apr 8;13(8):1939-1959. doi: 10.1039/d4bm01677g.
3
Lived Experiences of Self-Care in Older Adults with Lymphoma Undergoing Chemotherapy Treatments During the COVID-19 Pandemic.新冠疫情期间接受化疗的老年淋巴瘤患者自我护理的生活体验
Healthcare (Basel). 2025 Jan 15;13(2):157. doi: 10.3390/healthcare13020157.
4
Time toxicity in cancer care: A concept analysis using Walker and Avant's method.癌症护理中的时间毒性：运用沃克和阿凡特方法的概念分析
Asia Pac J Oncol Nurs. 2024 Oct 23;11(12):100610. doi: 10.1016/j.apjon.2024.100610. eCollection 2024 Dec.
5
Serious Gaming for Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer: Protocol for a Randomized Clinical Trial.针对老年癌症患者化疗引起的恶心和呕吐的严肃游戏：一项随机临床试验方案
JMIR Res Protoc. 2024 Oct 2;13:e64673. doi: 10.2196/64673.
6
Effectiveness of Artificial Intelligence Technologies in Cancer Treatment for Older Adults: A Systematic Review.人工智能技术在老年癌症治疗中的有效性：一项系统综述。
J Clin Med. 2024 Aug 23;13(17):4979. doi: 10.3390/jcm13174979.
7
Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies.制定一项将老年综合评估纳入老年血液系统恶性肿瘤患者治疗的全国性研究。
Curr Oncol Rep. 2024 Nov;26(11):1349-1354. doi: 10.1007/s11912-024-01600-y. Epub 2024 Sep 11.
8
Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis.抗血管生成酪氨酸激酶抑制剂相关毒性在癌症患者中的系统评价和荟萃分析。
Target Oncol. 2024 Jul;19(4):533-545. doi: 10.1007/s11523-024-01067-8. Epub 2024 May 18.
9
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.转移性三阴性乳腺癌中戈沙妥珠单抗3期ASCENT研究的亚组分析。
NPJ Breast Cancer. 2024 Apr 25;10(1):33. doi: 10.1038/s41523-024-00635-5.
10
The levels and trends of cancer incidence in the elderly population at national and sub-national scales in Iran from 1990 to 2016.1990年至2016年伊朗全国及国家以下各级老年人口癌症发病率水平及趋势。
Cancer Rep (Hoboken). 2024 Jan;7(1):e1937. doi: 10.1002/cnr2.1937. Epub 2023 Dec 4.

本文引用的文献

1
Personalizing therapy for older adults with acute myeloid leukemia: Role of geriatric assessment and genetic profiling.为老年急性髓系白血病患者制定个体化治疗方案：老年评估和基因谱分析的作用。
Cancer Treat Rev. 2019 May;75:52-61. doi: 10.1016/j.ctrv.2019.04.001. Epub 2019 Apr 11.
2
Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia.八旬急性髓系白血病患者的治疗模式与预后
Am J Hematol. 2019 Jun;94(6):E169-E172. doi: 10.1002/ajh.25464. Epub 2019 Apr 1.
3
Understanding patients' values and priorities in selecting cancer treatments: Developing a therapy preference scale.了解患者在选择癌症治疗方法时的价值观和优先事项：制定治疗偏好量表。
J Geriatr Oncol. 2019 Sep;10(5):677-679. doi: 10.1016/j.jgo.2018.11.005. Epub 2018 Nov 27.
4
Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States.美国新诊断急性髓系白血病初始化疗的应用。
Blood Adv. 2018 Jun 12;2(11):1277-1282. doi: 10.1182/bloodadvances.2018019125.
5
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.老年化疗患者脆弱性的实用评估和管理：ASCO 老年肿瘤学指南。
J Clin Oncol. 2018 Aug 1;36(22):2326-2347. doi: 10.1200/JCO.2018.78.8687. Epub 2018 May 21.
6
Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia.与老年急性髓系白血病患者造血细胞移植利用率较低相关的社会经济和卫生系统因素。
Bone Marrow Transplant. 2018 Oct;53(10):1288-1294. doi: 10.1038/s41409-018-0164-y. Epub 2018 Mar 27.
7
Racial and ethnic disparities in hematologic malignancies.血液系统恶性肿瘤中的种族和民族差异。
Blood. 2017 Oct 12;130(15):1699-1705. doi: 10.1182/blood-2017-04-778225. Epub 2017 Jul 19.
8
Initial therapy for acute myeloid leukemia in older patients: principles of care.老年患者急性髓系白血病的初始治疗：护理原则
Leuk Lymphoma. 2018 Jan;59(1):29-41. doi: 10.1080/10428194.2017.1323275. Epub 2017 Jun 2.
9
Early mortality and overall survival of acute myeloid leukemia based on facility type.基于医疗机构类型的急性髓系白血病的早期死亡率和总生存率。
Am J Hematol. 2017 Aug;92(8):764-771. doi: 10.1002/ajh.24767. Epub 2017 Jun 1.
10
Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma.霍奇金淋巴瘤幸存者中的继发性急性髓系白血病
Future Oncol. 2016 Jul;12(13):1565-75. doi: 10.2217/fon-2016-0048. Epub 2016 Apr 15.

Cancer in older adults: understanding cause and effects of chemotherapy-related toxicities.

作者信息

Bhatt Vijaya R

机构信息

Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

Future Oncol. 2019 Aug;15(22):2557-2560. doi: 10.2217/fon-2019-0159. Epub 2019 Jul 24.

DOI:10.2217/fon-2019-0159
PMID:31339058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857338/
Abstract
摘要